CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2020
Shares 300,000 Value ($000) $966 Avg Close — Range —